Comirnaty Vaccine: The Latest in COVID-19 Immunization

What is Comirnaty?

Comirnaty is the brand name for the first COVID-19 vaccine to receive full approval from the U.S. Food and Drug Administration (FDA). It is a messenger RNA (mRNA) vaccine, which means it contains genetic material that instructs the body's cells to produce the spike protein of the SARS-CoV-2 virus. This protein is what the virus uses to enter human cells.

How does Comirnaty work?

When a person is vaccinated with Comirnaty, their body produces the spike protein, which is recognized by the immune system. The immune system then produces antibodies against the spike protein, which can help protect the person from future infection with SARS-CoV-2.

Who is eligible for Comirnaty?

Comirnaty is currently authorized for use in people 16 years of age and older. People with certain underlying medical conditions, such as heart disease, lung disease, or diabetes, are at higher risk of severe illness from COVID-19 and should get vaccinated as soon as possible.

How effective is Comirnaty?

In clinical trials, Comirnaty was found to be 95% effective in preventing symptomatic COVID-19 infection. The vaccine was also found to be effective in preventing severe illness and death from COVID-19.

What are the side effects of Comirnaty?

The most common side effects of Comirnaty are pain, redness, and swelling at the injection site. Other side effects, such as fatigue, headache, muscle pain, and chills, are also possible.

How can I get vaccinated with Comirnaty?

Comirnaty is available at pharmacies, doctor's offices, and other healthcare facilities. You can schedule an appointment to get vaccinated by calling your doctor or visiting the website of your local health department.

Additional information

For more information about Comirnaty, please visit the website of the Centers for Disease Control and Prevention (CDC): https://www.cdc.gov/coronavirus/2019-ncov/vaccines/comirnaty.html

Comirnaty Vaccine